Advertisement

Pocket histology at cardiac implantable electronic device replacement: What’s new?

Published:October 26, 2022DOI:https://doi.org/10.1016/j.hrthm.2022.10.017

      Background

      Repeated procedures involving the cardiac implantable electronic device (CIED) pocket increase the infection risk, and the extent of pocket adhesions may prolong the procedure time. Few data on pocket histology at CIED replacement are available.

      Objective

      The purpose of this study was to describe CIED pocket histology in a cohort of patients undergoing CIED replacement or upgrade.

      Methods

      All consecutive patients undergoing CIED replacement or upgrade at our center between November 2019 and May 2020 were enrolled. Subclinical pocket infection was ruled out by physical inspection and laboratory parameters before the procedure. Pocket tissue specimens from the anterior and posterior pockets were obtained intraoperatively. A systematic histological analysis of capsular thickness, fibrous connective tissue, neovascularization, inflammation, and calcifications was performed.

      Results

      Thirty patients (20% women) were enrolled. The mean capsular thickness was 0.8 ± 0.3 mm in the anterior wall and 1.1 ± 0.4 mm in the posterior wall. Subcapsular fibrosis was mild and multifocal in the anterior wall and moderate and focal in the posterior wall. Neovascularization was focal in most cases, and vessel remodeling mainly involved the tunica media. Chronic inflammation was usually mild and nongranulomatous, and in a quarter of cases, subacute exudative fibrous inflammation was detected in the posterior pocket wall.

      Conclusion

      The CIED pocket is a histopathologically dynamic environment, given the coexistence of both a subacute foreign body response and fibrous tissue growth, implying continuous remodeling due to an injury-repair mechanism. Strategies to interact with foreign body response might minimize inflammatory pocket activity, especially device encapsulation by tight fibrous tissue, and possibly complications related to repeated CIED procedures.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arana-Rueda E.
        • Pedrote A.
        • Frutos-Lopez M.
        • et al.
        Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
        Clin Cardiol. 2017; 40: 892-898
        • Borleffs C.J.
        • Thijssen J.
        • de Bie M.K.
        • et al.
        Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.
        Pacing Clin Electrophysiol. 2010; 33: 1013-1019
        • Biffi M.
        The never-ending story of CIED infection prevention: shall we WRAP-IT and go?.
        J Cardiovasc Electrophysiol. 2019; 30: 1191-1196
        • Hassoun A.
        • Thottacherry E.D.
        • Raja M.
        • Scully M.
        • Azarbal A.
        Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
        J Hosp Infect. 2017; 95: 286-291
        • Biffi M.
        • Ammendola E.
        • Menardi E.
        • et al.
        Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
        Europace. 2019; 21: 1527-1536
        • Robotti F.
        • Bottan S.
        • Fraschetti F.
        • et al.
        A micron-scale surface topography design reducing cell adhesion to implanted materials.
        Sci Rep. 2018; 810887
        • Biefer H.R.
        • Hurlimann D.
        • Grunenfelder J.
        • et al.
        Generator pocket adhesions of cardiac leads: classification and correlation with transvenous lead extraction results.
        Pacing Clin Electrophysiol. 2013; 36: 1111-1116
        • Sticherling C.
        • Marin F.
        • Birnie D.
        • et al.
        Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).
        Europace. 2015; 17: 1197-1214
        • Birnie D.H.
        • Healey J.S.
        • Wells G.A.
        • et al.
        Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
        Eur Heart J. 2018; 39: 3973-3979
        • Birnie D.H.
        • Healey J.S.
        • Wells G.A.
        • et al.
        • BRUISE CONTROL Investigators
        Pacemaker or defibrillator surgery without interruption of anticoagulation.
        N Engl J Med. 2013; 368: 2084-2093
        • Cassagneau R.
        • Ploux S.
        • Ritter P.
        • et al.
        Long-term outcomes after pocket or scar revision and reimplantation of pacemakers with preerosion.
        Pacing Clin Electrophysiol. 2011; 34: 150-154
        • Poole J.E.
        • Gleva M.J.
        • Mela T.
        • et al.
        Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
        Circulation. 2010; 122: 1553-1561
        • Maytin M.
        • John R.M.
        • Epstein L.M.
        Device pocket scar predicts transvenous lead extraction difficulty.
        J Innov Card Rhythm Manag. 2015; 6: 2173-2177
        • Rudolph R.
        • Utley J.R.
        • Woodward M.
        Contractile fibroblasts (myofibroblasts) in a painful pacemaker pocket.
        Ann Thorac Surg. 1981; 31: 373-376
        • Steckiewicz R.
        • Swieton E.B.
        • Kolodzinska A.
        • Bogdanska M.
        • Fus L.
        • Solarz P.
        Morphometric parameters of cardiac implantable electronic device (CIED) pocket walls observed on device replacement.
        Folia Morphol (Warsz). 2017; 76: 675-681
        • Anderson J.M.
        • Rodriguez A.
        • Chang D.T.
        Foreign body reaction to biomaterials.
        Semin Immunol. 2008; 20: 86-100
        • Wynn T.A.
        Cellular and molecular mechanisms of fibrosis.
        J Pathol. 2008; 214: 199-210
        • Mittal S.
        • Wilkoff B.L.
        • Kennergren C.
        • et al.
        The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: long-term follow-up.
        Heart Rhythm. 2020; 17: 1115-1122
        • Ellis C.R.
        Histology of total capsulectomy after pulse generator replacement with an absorbable antibacterial envelope.
        Heart Rhythm Society Congress, 2019
        • Haferland I.
        • Wallenwein C.M.
        • Ickelsheimer T.
        • et al.
        Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa.
        Exp Dermatol. 2022; 31: 1005-1013
        • Hu G.
        • Xu C.
        • Staudinger J.L.
        Pregnane X receptor is SUMOylated to repress the inflammatory response.
        J Pharmacol Exp Ther. 2010; 335: 342-350